Cargando…
Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
BACKGROUND: Rapid drug desensitization (RDD) allows first-line therapies in patients with immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD) and monoclonal antibodies (mAb). Desensitization in delayed drug reactions has traditionally used slow protocols extending up to s...
Autores principales: | Vega, Arantza, Peña, M. Isabel, Torrado, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974726/ https://www.ncbi.nlm.nih.gov/pubmed/35387014 http://dx.doi.org/10.3389/falgy.2021.786863 |
Ejemplares similares
-
Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014) -
Allergic diseases of the skin and drug allergies – 2017. Rapid desensitization for delayed reactions to chemotherapy and monoclonal antibodies
por: Vega Castro, Maria Aranzazu, et al.
Publicado: (2013) -
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023) -
Case report: desensitization of hypersensitivity against the antisense oligonucleotide volanesorsen
por: Isaac, Rafael H., et al.
Publicado: (2023) -
Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol
por: Kim, Hyun Hwa, et al.
Publicado: (2022)